Abstract
Widespread structural brain abnormalities have been consistently reported in schizophrenia, but their relation to the heterogeneous clinical manifestations remains unknown. In particular, it is un-clear whether anatomical abnormalities in discrete regions give rise to discrete symptoms, or whether distributed abnormalities give rise to the broad clinical profile associated with schizophrenia. Here we apply a multivariate data-driven approach to investigate covariance patterns between multiple symptom domains and distributed brain abnormalities in schizophrenia. Structural MRI, and clinical data were derived from one discovery sample (133 patients, 113 controls) and one independent validation sample (108 patients, 69 controls). Disease-related voxel-wise brain abnormalities were estimated using deformation based morphometry. Partial least squares analysis was used to comprehensively map clinical, neuropsychological and demographic data onto distributed deformation in a single multivariate model. The analysis identified three latent clinical-anatomical dimensions that collectively accounted for 55% of the covariance between clinical data and brain deformation. The first latent clinical-anatomical dimension was replicated in an independent sample, encompassing cognitive impairments, negative symptom severity and brain abnormalities within the default mode and visual networks. This cognitive-negative dimension was associated with low socioeconomic status and was represented across multiple races. Altogether, we identified a continuous cognitive-negative dimension of schizophrenia, centered on two intrinsic networks. By simultaneously taking into account both clinical manifestations and neuroanatomical abnormalities, the present results open new avenues for multi-omic stratification and biotyping of individuals with schizophrenia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was undertaken thanks in part to funding from the Canada First Research Excellence Fund, awarded to McGill University for the Healthy Brains for Healthy Lives initiative. MK acknowledges support from the National Bank Fellowship (McGill University) and the Swiss National Foundation (P2SKP3_178175). BM acknowledges support from the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery Grant RGPIN #017-04265) and from the Fonds de recherche du Québec - Santé (Chercheur Boursier). GS acknowledges support from the Natural Sciences and Engineering Research Council of Canada (NSERC) and from the Healthy Brains for Healthy Lives (HBHL) initiative at McGill University. CM acknowledges support from the Canadian Institutes of Health Research (CIHR).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Deformation patterns of the clinical-anatomical dimensions are freely available for visualization and download for further exploration and future research from Neurovault (https://identifiers.org/neurovault.collection:6825).
